Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
Study sponsor: BioAge Labs, Inc. · BIOA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-02-06Actual
Enrollment · participants204Actual
Source updated2025-03-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.